Poor Ovarian Responders
Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial
10
GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?
7
Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization
5
The Challenge of Improving IVF Results in Normogonadotrophic (Unexpected) Young Poor Ovarian Responders: The Predictive Value of a Flexible Treatment Protocol Based on the “Biophysical Profile of the Uterus”
11
Original Article Effectiveness of dehydroepiandrosterone in poor ovarian responders undergoing in vitro fertilization: a meta-analysis of randomized controlled trials
14
Bone morphogenetic protein-15 in follicle fluid combined with age may differentiate between successful and unsuccessful poor ovarian responders
6
Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study
9
Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection
6
Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial
8
Follicular flushing increases the number of oocytes retrieved in poor ovarian responders undergoing in vitro fertilization: a retrospective cohort study
7
Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: An RCT
8
Strategies for Pituitary Down-regulation to Optimize IVF/ICSI Outcome in Poor Ovarian Responders
7
Comparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian Responders
7
Corifollitropin alfa for poor responders patients, a prospective randomized study
6
Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial
8
Individualized controlled ovarian stimulation in expected poor-responders: an update
9
Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy
7
Does Dehydroepiandrosterone (DHEA) improve in vitro fertilisation (IVF) outcomes in poor responders?
5
Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders
9
Presence of the full length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment
6